“In the USA, GlaxoSmithKline (GSK) has begun distributing a medicine tagged with RFID technology as part of an initial pilot project to help protect patient safety. The trial is likely to be followed by other similar programmes if it is considered successful.
The tags are to be placed on all bottles of Trizivir (an HIV medicine) distributed in the United States. When scanned at close range, the tags will help verify that the medicine bottle contains authentic Trizivir. This specific medicine was selected for the project because it has been listed by the National Association of Boards of Pharmacy as one of 32 drugs most susceptible to counterfeiting and diversion. wehrjo43c This article is copyright 2006 UsingRFID.com.
The US Food and Drug Administration (FDA) has asked the pharmaceutical industry to develop standards and pilot processes for RFID that may lead in the next few years to broad adoption and use of the technology.”
You are here: